Advanced Medical Solutions Group (CHIX:AMSL) PE Ratio: 61.78 (As of Jun. 26, 2026) — 84% Above Median


CHIX:AMSL Advanced Medical Solutions Group PLC CHIX:AMSL
93 GF Score
Price £2.78
GF Value £3.71
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Advanced Medical Solutions Group PE Ratio?

Advanced Medical Solutions Group CHIX:AMSL +14.17% 93 PE Ratio is 61.78 as of Jun. 26, 2026, which is 84% above its 10-year median of 33.50. GuruFocus rates CHIX:AMSL with a GF Score™ of 93/100 and a GF Value™ of £3.71 (Modestly Undervalued). The stock has 6 warning signs investors should review.

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2026-06-26), Advanced Medical Solutions Group's share price is £2.78. Advanced Medical Solutions Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was £0.05. Therefore, Advanced Medical Solutions Group's PE Ratio for today is 61.78.

During the past 13 years, Advanced Medical Solutions Group's highest PE Ratio was 86.15. The lowest was 19.53. And the median was 33.50.

Advanced Medical Solutions Group's EPS (Diluted) for the six months ended in Dec. 2025 was £0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was £0.05.

As of today (2026-06-26), Advanced Medical Solutions Group's share price is £2.78. Advanced Medical Solutions Group's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was £0.12. Therefore, Advanced Medical Solutions Group's PE Ratio without NRI ratio for today is 23.56.

During the past 13 years, Advanced Medical Solutions Group's highest PE Ratio without NRI was 62.22. The lowest was 16.39. And the median was 27.59.

Advanced Medical Solutions Group's EPS without NRI for the six months ended in Dec. 2025 was £0.06. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was £0.12.

During the past 12 months, Advanced Medical Solutions Group's average EPS without NRI Growth Rate was 11.40% per year. During the past 3 years, the average EPS without NRI Growth Rate was 3.70% per year. During the past 5 years, the average EPS without NRI Growth Rate was 12.00% per year. During the past 10 years, the average EPS without NRI Growth Rate was 3.40% per year.

During the past 13 years, Advanced Medical Solutions Group's highest 3-Year average EPS without NRI Growth Rate was 122.40% per year. The lowest was -23.30% per year. And the median was 14.75% per year.

Advanced Medical Solutions Group's EPS (Basic) for the six months ended in Dec. 2025 was £0.02. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was £0.05.

Back to Basics: PE Ratio


Advanced Medical Solutions Group  (CHIX:AMSl) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Advanced Medical Solutions Group PE Ratio Related Terms


Advanced Medical Solutions Group PE Ratio Historical Data

* Premium members only.

The historical data trend for Advanced Medical Solutions Group's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced Medical Solutions Group PE Ratio Chart

Advanced Medical Solutions Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.25 27.85 28.42 59.88 48.44

Advanced Medical Solutions Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.42 At Loss 59.88 At Loss 48.44

CHIX:AMSL vs ISRG, BDX, MDLN: PE Ratio Comparison

For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Medical Solutions Group PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's PE Ratio distribution charts can be found below:

* The bar in red indicates where Advanced Medical Solutions Group's PE Ratio falls into.


CHIX:AMSL
93GF Score
Advanced Medical Solutions Group PLC CHIX:AMSL
PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Advanced Medical Solutions Group PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Advanced Medical Solutions Group's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=2.78/0.045
=61.78

Advanced Medical Solutions Group's Share Price of today is £2.78.
For company reported semi-annually, Advanced Medical Solutions Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.05.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio →
What does a PE Ratio of 61.78 mean?
Advanced Medical Solutions Group (CHIX:AMSL) has a PE Ratio of 61.78 as of Jun. 26, 2026. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Advanced Medical Solutions Group and its competitors. This is 84% above median its historical median of 33.50. Over the past decade, Advanced Medical Solutions Group's PE Ratio has ranged from 19.53 to 86.15.
Is Advanced Medical Solutions Group's PE Ratio too high?
Advanced Medical Solutions Group's current PE Ratio of 61.78 is 84% above median its 10-year median of 33.50. Over the past 10 years, this metric has ranged from a low of 19.53 to a high of 86.15. Overall, Advanced Medical Solutions Group has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Advanced Medical Solutions Group's PE Ratio compare to ISRG and BDX?
Advanced Medical Solutions Group's PE Ratio of 61.78 can be compared against companies in the Medical Devices & Instruments industry. Historically, Advanced Medical Solutions Group's own PE Ratio has ranged from 19.53 to 86.15 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio for a Medical Devices & Instruments company?
A good PE Ratio depends on the Medical Devices & Instruments industry context. However, PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio mean?
A high PE Ratio can signal that a stock is expensive relative to its fundamentals. P/E ratio is the ratio of share price to a company's earnings per share. View historical data on Advanced Medical Solutions Group and its competitors. Advanced Medical Solutions Group's current PE Ratio is 61.78, which is 84% above median its own 10-year median of 33.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Medical Solutions Group stock overvalued right now?
Based on GuruFocus' analysis, Advanced Medical Solutions Group (CHIX:AMSL) is currently considered Modestly Undervalued. The stock's GF Value™ is £3.71, compared to a current price of £2.78 — trading 25.1% below its estimated fair value. The current PE Ratio is 61.78, which is 84% above median its 10-year median of 33.50. Advanced Medical Solutions Group's overall GF Score™ is 93/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio calculated?
PE Ratio is calculated from a company's financial statements. For Advanced Medical Solutions Group (CHIX:AMSL), the current PE Ratio is 61.78 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Advanced Medical Solutions Group (CHIX:AMSL) Overvalued in 2026?

Based on GuruFocus' analysis, Advanced Medical Solutions Group stock appears to be undervalued. The current stock price of £2.78 is trading 25.1% below its estimated GF Value™ of £3.71. GuruFocus considers Advanced Medical Solutions Group to be Modestly Undervalued.

Key valuation signals for CHIX:AMSL:

  • PE Ratio: 61.78 (84% above median its 10-year median of 33.50)
  • GF Value™: £3.71 vs. price of £2.78 (25.1% below fair value)
  • GF Score™: 93/100 with 6 warning signs

No single metric tells the full story. See the CHIX:AMSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Advanced Medical Solutions Group Business Description

Other Exchanges AMS:UKAQA:Germany
Address Premier Park, 33 Road One, Winsford Industrial Estate, Winsford, Cheshire, GBR, CW7 3RT
Advanced Medical Solutions Group PLC is engaged in developing and manufacturing wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical and Woundcare, of which the Surgical segment derives maximum revenue. Geographically, the company operates in the United Kingdom, Germany, France, the rest of Europe, the United States of America, and the rest of the world.
93GF Score

Get the complete analysis for CHIX:AMSL

PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£2.78
Price
£3.71
GF Value